{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "mesh:D009361",
      "entity_text" : "infiltration",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8NBP7",
      "entity_text" : "PCSK9",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Consistently, PCSK9 shRNA treatment partially attenuated the ischemic damage by decreasing vacuolization and neutrophil infiltration compared with that observed in the HFD-MCAO group (XREF_FIG).",
  "reading_complete" : "2020-08-03T18:07:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:07:10Z",
  "trigger" : "attenuated",
  "evidence" : [ "PCSK9 shRNA treatment partially attenuated the ischemic damage by decreasing vacuolization and neutrophil infiltration" ],
  "pmc_id" : "6108876",
  "score" : 0
}